Skip to main navigation Skip to search Skip to main content

Nonviral Delivery of CRISPR-Cas9 into Hepatocytes Combined with APAP Selection for Treatment of Familial Hypercholesterolemia

Project: Research

Project Details

StatusFinished
Effective start/end date09/1/24 → 06/30/26

Funding

  • National Heart Lung and Blood Institute: $18,444.00